A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy of Emblica officinalis in Uncontrolled Hypertension

Table 4

Response rate in each group.

	Group	Response 1, n (%)		Response 2, n (%)
SBP	EO	34 (82.9)	0.048	35 (85.4)	0.001
	Placebo	25 (62.5)		20 (50)
DBP	EO	39 (95.1)	0.007	34 (82.9)	<0.001
	Placebo	29 (72.5)		18 (45)

EO: Emblica officinalis, Response1: SBP < 140 and/or DBP < 90, Response2: reduction of SBP by more than 10 mm Hg, SBP: systolic blood pressure, and DBP: diastolic blood pressure.